4/11
04:30 pm
smmt
Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to its Board of Directors
Medium
Report
Summit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to its Board of Directors
4/10
07:05 am
smmt
Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum [Yahoo! Finance]
Low
Report
Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum [Yahoo! Finance]
4/10
07:00 am
smmt
Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum
Low
Report
Summit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum
4/9
04:39 pm
smmt
Illumina CFO Goswami to depart, Summit Therapeutics' Dhingra named successor [Yahoo! Finance]
Low
Report
Illumina CFO Goswami to depart, Summit Therapeutics' Dhingra named successor [Yahoo! Finance]
4/9
04:33 pm
smmt
Illumina appoints Ankur Dhingra as Chief Financial Officer [Seeking Alpha]
Low
Report
Illumina appoints Ankur Dhingra as Chief Financial Officer [Seeking Alpha]
3/29
05:52 pm
smmt
Why Summit Therapeutics Stock Crushed the Market This Week [Yahoo! Finance]
Medium
Report
Why Summit Therapeutics Stock Crushed the Market This Week [Yahoo! Finance]
3/28
05:37 am
smmt
Akeso Marks Profit Milestone With Swift Rights Issue [Seeking Alpha]
Medium
Report
Akeso Marks Profit Milestone With Swift Rights Issue [Seeking Alpha]
3/26
08:13 am
smmt
Summit Therapeutics Inc. (NASDAQ: SMMT) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $8.00 price target on the stock.
Medium
Report
Summit Therapeutics Inc. (NASDAQ: SMMT) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $8.00 price target on the stock.
3/25
11:09 am
smmt
Summit Therapeutics Insiders Up US$5.1m On US$5.05m Investment [Yahoo! Finance]
Medium
Report
Summit Therapeutics Insiders Up US$5.1m On US$5.05m Investment [Yahoo! Finance]
3/23
06:52 am
smmt
China Powerwoman's Akeso Raises $150 Mln After First Profit [Forbes]
Medium
Report
China Powerwoman's Akeso Raises $150 Mln After First Profit [Forbes]
3/22
07:10 am
smmt
Promising Intracranial Anti-Tumor Activity and Safety Data for Ivonescimab in NSCLC Patients with Brain Metastases Featured at ELCC 2024 [Yahoo! Finance]
Medium
Report
Promising Intracranial Anti-Tumor Activity and Safety Data for Ivonescimab in NSCLC Patients with Brain Metastases Featured at ELCC 2024 [Yahoo! Finance]
3/22
07:00 am
smmt
Promising Intracranial Anti-Tumor Activity and Safety Data for Ivonescimab in NSCLC Patients with Brain Metastases Featured at ELCC 2024
Medium
Report
Promising Intracranial Anti-Tumor Activity and Safety Data for Ivonescimab in NSCLC Patients with Brain Metastases Featured at ELCC 2024
3/14
07:11 am
smmt
Intracranial Anti-Tumor Activity and Safety of Ivonescimab in NSCLC Patients with Brain Metastases to be Featured at ELCC 2024 [Yahoo! Finance]
Medium
Report
Intracranial Anti-Tumor Activity and Safety of Ivonescimab in NSCLC Patients with Brain Metastases to be Featured at ELCC 2024 [Yahoo! Finance]
3/14
07:00 am
smmt
Intracranial Anti-Tumor Activity and Safety of Ivonescimab in NSCLC Patients with Brain Metastases to be Featured at ELCC 2024
Medium
Report
Intracranial Anti-Tumor Activity and Safety of Ivonescimab in NSCLC Patients with Brain Metastases to be Featured at ELCC 2024
3/11
06:05 pm
smmt
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeutics Inc. - SMMT
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeutics Inc. - SMMT
3/9
12:00 pm
smmt
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeutics Inc. - SMMT
Medium
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeutics Inc. - SMMT
3/7
03:56 pm
smmt
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeutics Inc. - SMMT
Low
Report
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Summit Therapeutics Inc. - SMMT
3/6
04:40 am
smmt
Shareholders that lost money on Summit Therapeutics Inc. (SMMT) should contact Levi & Korsinsky about Securities Fraud Investigation - SMMT
Medium
Report
Shareholders that lost money on Summit Therapeutics Inc. (SMMT) should contact Levi & Korsinsky about Securities Fraud Investigation - SMMT
3/6
04:35 am
smmt
Lost Money on Summit Therapeutics Inc.(SMMT)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
Medium
Report
Lost Money on Summit Therapeutics Inc.(SMMT)? Contact Levi & Korsinsky Regarding an Ongoing Investigation
3/6
04:00 am
smmt
Summit Therapeutics Inc. (SMMT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Medium
Report
Summit Therapeutics Inc. (SMMT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
3/5
03:50 pm
smmt
Summit Therapeutics Being Investigated on Behalf of Summit Therapeutics Inc. Investors. Contact Levi & Korsinsky For Details.
Low
Report
Summit Therapeutics Being Investigated on Behalf of Summit Therapeutics Inc. Investors. Contact Levi & Korsinsky For Details.
3/5
12:15 pm
smmt
Lost Money on Summit Therapeutics Inc.(SMMT)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
Medium
Report
Lost Money on Summit Therapeutics Inc.(SMMT)? You May Have Been Affected by Fraud - Contact Levi & Korsinsky
3/5
07:00 am
smmt
Summit Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conference
High
Report
Summit Therapeutics to Present at the Barclays 26th Annual Global Healthcare Conference
3/5
04:00 am
smmt
Summit Therapeutics Inc. (SMMT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
High
Report
Summit Therapeutics Inc. (SMMT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
3/4
04:00 am
smmt
Summit Therapeutics Inc. (SMMT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Medium
Report
Summit Therapeutics Inc. (SMMT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings